Dose prescription and treatment planning based on FMISO-PET hypoxia
暂无分享,去创建一个
Anders Brahme | Karin Haustermans | Iuliana Toma-Dasu | Alexandru Dasu | Sandra Nuyts | Piet Dirix | K. Haustermans | I. Toma-Dasu | P. Dirix | S. Nuyts | Johan Uhrdin | Laura Antonovic | A. Dasu | L. Antonovic | J. Uhrdin | Anders Brahme
[1] D. Hristov,et al. Adapting radiotherapy to hypoxic tumours , 2006, Physics in medicine and biology.
[2] D. Olsen,et al. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study , 2007, Physics in medicine and biology.
[3] A. Brahme,et al. Biologically Optimized 3-Dimensional In Vivo Predictive Assay-based Radiation Therapy Using Positron Emission Tomography-Computerized Tomography Imaging , 2003, Acta oncologica.
[4] Søren M Bentzen,et al. Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.
[5] S. Apisarnthanarax,et al. Current Imaging Paradigms in Radiation Oncology , 2005, Radiation research.
[6] A H Baydush,et al. Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. , 2004, Medical physics.
[7] A Brahme,et al. Individualizing cancer treatment: biological optimization models in treatment planning and delivery. , 2001, International journal of radiation oncology, biology, physics.
[8] A. J. Varghese,et al. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. , 1976, Cancer research.
[9] R. Jeraj,et al. Feasibility and sensitivity study of helical tomotherapy for dose painting plans , 2010, Acta oncologica.
[10] Mikael Karlsson,et al. Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia. , 2003, Physics in medicine and biology.
[11] TIKVAH ALPER,et al. Role of Oxygen in Modifying the Radiosensitivity of E. Coli B. , 1956, Nature.
[12] Alexandru Daşu,et al. Should single or distributed parameters be used to explain the steepness of tumour control probability curves? , 2003, Physics in medicine and biology.
[13] C. Anderson,et al. Radiation Oncology , 2001, Springer International Publishing.
[14] T. Alper,et al. Cellular radiobiology. , 1960, Annual review of nuclear science.
[15] C. Ling,et al. Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. , 2009, International journal of radiation oncology, biology, physics.
[16] Alexandru Daşu,et al. Treatment modelling: The influence of micro-environmental conditions , 2008, Acta oncologica.
[17] P Vaupel,et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] Jens Overgaard,et al. Resolution in PET hypoxia imaging: Voxel size matters , 2008, Acta oncologica.
[19] G. Barendsen,et al. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. , 1982, International journal of radiation oncology, biology, physics.
[20] H D Thames,et al. Time-dose factors in radiotherapy: a review of the human data. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] J. Chapman,et al. The detection and measurement of hypoxic cells in solid tumors , 1984, Cancer.
[22] Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome , 1998 .
[23] A. Waites,et al. Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy? , 1998, Advances in enzyme regulation.
[24] Daniela Thorwarth,et al. Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.
[25] A Brahme,et al. Volume and heterogeneity dependence of the dose-response relationship for head and neck tumours. , 1995, Acta oncologica.
[26] Tomio Inoue,et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] Frederik Maes,et al. Biological image-guided radiotherapy in rectal cancer: Is there a role for FMISO or FLT, next to FDG? , 2008, Acta oncologica.
[28] Robert Jeraj,et al. Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. , 2008, Physics in medicine and biology.
[29] Peter Vaupel,et al. Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.
[30] J F Fowler,et al. Letter: Fractionation schedules and a quadratic dose-effect relationship. , 1975, The British journal of radiology.
[31] M Alber,et al. On biologically conformal boost dose optimization. , 2003, Physics in medicine and biology.
[32] J. Fowler. The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.
[33] Daniela Thorwarth,et al. Implementation of hypoxia imaging into treatment planning and delivery. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[34] Anders Brahme,et al. Dose prescription and optimisation based on tumour hypoxia , 2009, Acta oncologica.
[35] Sigrid Stroobants,et al. Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI , 2009, Journal of Nuclear Medicine.
[36] A. Boyer,et al. Inverse planning for functional image-guided intensity-modulated radiation therapy. , 2002, Physics in medicine and biology.
[37] J. Denekamp,et al. Inducible repair and the two forms of tumour hypoxia--time for a paradigm shift. , 1999, Acta oncologica.
[38] M J Welch,et al. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[39] Michael Höckel,et al. Detection and characterization of tumor hypoxia using pO2 histography. , 2007, Antioxidants & redox signaling.
[40] J. Bussink,et al. Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. , 2002, International journal of radiation oncology, biology, physics.
[41] C C Ling,et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.
[42] Alexandru Daşu,et al. Treatment planning optimisation based on imaging tumour proliferation and cell density , 2008, Acta oncologica.
[43] D. Hedley,et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] Anders Brahme,et al. Therapy optimization based on non-linear uptake of PET tracers versus “linear dose painting” , 2009 .
[45] Gig Mageras,et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.
[46] K L Lindsley,et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. , 1995, International journal of radiation oncology, biology, physics.
[47] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[48] A. Scott,et al. Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole. , 2007, Seminars in nuclear medicine.
[49] M. Schwaiger,et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.
[50] A. Brahme,et al. Optimal dose distribution for eradication of heterogeneous tumours. , 1987, Acta oncologica.
[51] J. Hendry,et al. Radiobiology for the Radiologist , 1979, British Journal of Cancer.
[52] Jens Overgaard,et al. Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.